NYSCF Congratulates Geron: First Embryonic Stem-Cell Trial Gets Approval From the FDA
NYSCF applauds the FDA approval of Geron’s pioneering human embryonic stem cell clinical trial which Tom Okarma, Geron’s president...NYSCF applauds the FDA approval of Geron’s pioneering human embryonic stem cell clinical trial which Tom Okarma, Geron’s president and CEO, and Hans Kierstead, of the University of California, previewed at NYSCF’s annual translational conference in October.
NEW YORK, NY (January 23, 2009) – NYSCF applauded the announcement of the FDA approval of Geron’s pioneering human embryonic stem cell clinical trial. Tom Okarma, Geron’s president and CEO, and Hans Kierstead, of the University of California, previewed at NYSCF’s annual translational conference in October.
NYSCF CEO Susan L. Solomon noted: “The FDA’s announcement that it has given approval for the first human clinical trial involving embryonic stem cells is a watershed moment in the relatively short, yet remarkable history of stem cell science and regenerative medicine. This is a critical step forward that signals a new era of federal support of the promise of embryonic stem cell research.”